I-Tenofovir Disoproxil Fumarate CAS 202138-50-9 Assay 98.0%~102.0% API Factory
I-Tenofovir Commercial Related Intermediate:
I-Tenofovir CAS: 147127-20-6
I-Tenofovir Disoproxil Fumarate CAS 202138-50-9
I-Tenofovir Alafenamide Hemifumarate CAS 1392275-56-7
I-Chloromethyl Isopropyl Carbonate CAS 35180-01-9
I-Diethyl (p-Toluenesulfonyloxymethyl)phosphonate CAS 31618-90-3
(R)-(+)-Propylene Carbonate CAS 16606-55-6
(R)-9-(2-Hydroxypropyl)adenine CAS 14047-28-0
I-Diethyl (Hydroxymethyl)phosphonate CAS 3084-40-0
I-Adenine CAS 73-24-5
Igama Lekhemikhali | I-Tenofovir Disoproxil Fumarate |
Omqondofana | I-Tenofovir DF;I-Bis(POC)-PMPA Fumarate;GS 4331 Fumarate |
Inombolo ye-CAS | 202138-50-9 |
Inombolo yeCAT | I-RF-API106 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C23H34N5O14P |
Isisindo samangqamuzana | 635.52 |
I-Melting Point | 113.0 ukuze 115.0 ℃ |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Emhlophe noma Ecishe Emhlophe |
Ukuhlonza A | I-IR Spectrum Ihambisana Nezinga Lereferensi |
Ukuhlonza B | Isikhathi sokugcina sesiqongo esikhulu esivela kusixazululo sesampula sihambisana naleso sesixazululo esijwayelekile, njengoba sitholwe ekuhlolweni. |
Isivivinyo | 98.0%~102.0% (kwisisekelo se-anhydrous) |
Amanzi | ≤1.0% |
I-Fumaric Acid | 17.5%~19.0% |
Izinsalela ekushiseni | ≤0.20% |
Izinsimbi Ezisindayo | ≤20ppm |
I-Chloromethyl isopropyl carbonate | ≤0.15% |
Izinto Ezihlobene | |
I-Tenofovir | ≤0.15% |
I-Adenine | ≤0.15% |
I-Tenofovir Isoproxi Monoester | ≤1.0% |
I-Tenofovir Disoproxil Ethyl Ester | ≤0.15% |
I-Tenofovir Isopropyl Isoproxil | ≤0.30% |
I-Tenofovir Disoproxil Carbamate | ≤0.15% |
I-Tenofovir Disproxil | ≤0.15% |
Noma Ikuphi Ukungcola Okukodwa | ≤0.10% |
Ukungcola Okuphelele | ≤2.0% |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-API |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.
I-Tenofovir Disoproxil Fumarate (CAS: 202138-50-9), i-prodrug ye-tenofovir (Igama lokuhweba: Viread) ethuthukiswe i-Gilead Sciences, iwuhlobo lwezidakamizwa ze-nucleotide-analogues ze-antiretroviral, eziqala ukusebenza ngokusebenza njenge-reverse transcriptase inhibitors[nRTIs] , evimba i-reverse transcriptase, i-enzyme ebalulekile ekukhiqizeni amagciwane kubantu abane-HIV.Kufanele kuqashelwe ukuthi iyi-nucleotide reverse transcriptase inhibitor yokuqala eyake yasetshenziswa ekwelapheni ukutheleleka nge-HIV.I-Tenofovir Disoproxil Fumarate iguqulelwa ku-tenofovir in vivo, okuyi-acyclic nucleoside phosphonate[nucleotide] analog ye-adenosine 5'-monophosphate.Ngokuvamile isetshenziswa ngokuhlanganiswa nezinye izinhlobo zemithi.Imithi ye-HIV ayikwazi ukwelapha i-HIV/AIDS, kodwa ukuphuza inhlanganisela yemithi ye-HIV [okuthiwa uhlelo lwe-HIV] nsuku zonke kungasiza abantu abane-HIV baphile isikhathi eside, izimpilo ezinempilo.Ngokusekelwe kumbhalo we-FDA, i-tenofovir disoproxil fumarate ingaba futhi eyokwelapha ukutheleleka kwegciwane le-hepatitis B [HBV] elingamahlalakhona kubantu abadala nasezinganeni ezineminyaka engu-12 nangaphezulu.